Acyclovir triphosphate (sodium)
Acyclovir triphosphate (Synonyms: AcycloGTP) sodium is a Acyclovir derivative that competitively inhibits viral DNA polymerase by acting as an analog to deoxyguanosine triphosphate (dGTP). Acyclovir triphosphate sodium is an inhibitor of HIV-1 reverse transcriptase. Acyclovir triphosphate sodium causes termination of viral DNA synthesis[1].
Product Specifications
CAS Number
221119-43-3
Product Name Alternative
AcycloGTP (sodium)
UNSPSC
12352200
Target
DNA/RNA Synthesis; HIV; Nucleoside Antimetabolite/Analog; Reverse Transcriptase
Type
Biochemical Assay Reagents
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/acyclovir-triphosphate-sodium.html
Concentration
100 mM * 500 μL in water
Purity
99.71
Smiles
O=P(OP(OP(OCCOCN1C(N=C(N)NC2=O)=C2N=C1)(O)=O)(O)=O)(O)O.[x].[Na]
Molecular Formula
C8H14N5O12P3.xNa
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
VEGF-R2 / CD309 / Flk-1 / KDR3 (DC101), CF594 conjugate, 0.1mg/mL
